Asst. Prof. MD. Cengiz Akosman

Education and Specialization

• 1994 - 2001 - Undergraduate - Istanbul University Cerrahpaşa Faculty of Medicine, English Medicine Department

• 2002 - 2007 - Master's/Specialization - Internal Medicine - SB Haydarpaşa Training and Research Hospital

• 2007 - 2010 - Ph.D./Subspecialty - Medical Oncology - Yeditepe University Hospital Oncology Department

Experience

• 2012 - 2013 - Erzurum Training and Research Hospital, Medical Oncology Clinic Responsible Doctor

• Medical Park Ordu Ethics Committee Member

• Medical Park Ordu Transfusion Committee Member

Professional Memberships

• Turkish Society of Medical Oncology (TTOD)

• American Society of Clinical Oncology (ASCO)

• European Society of Medical Oncology (ESMO)

• Turkish Oncology Group Association (TOG)

• Turkish Society of Internal Medicine Specialists

• Oncology and Immunotherapy Association

• Ordu Chamber of Physicians

Articles Published in International Peer-Reviewed Journals (SCI & SSCI & Arts and Humanities)

1. Akosman C, N.A. Selcuk, C. Ordu, S. Ercan, I.D. Ekici, B.Oyan. Unicentric mixed variant Castleman disease associated with Hashimoto disease: the role of PET/CT in staging and evaluating response to the treatment. Cancer Imaging. 2011; 11(1): 52–55.

2. Akosman C., C. Ordu, E. Eroglu, B. Oyan. Development of acute pulmonary hypertension after bortezomib treatment in a patient with multiple myeloma: A case report and the review of the literature. Am J Ther. 2015 May-Jun;22(3):e88-92. doi: 10.1097/01.

3. Cetin Ordu, Nalan A Selcuk, Cengiz Akosman, Orhan Onder Eren, Elif C Altunok, Turkay Toklu, Basak Oyan. Comparison of Metabolic and Anatomic Response to Chemotherapy Based on PERCIST and RECIST in Patients with Advanced Stage Non-small Cell Lung Cancer. Asian Pac J Cancer Prev, 16 (1), 321-326.

4. Orhan Onder Eren, Cetin Ordu, Nalan A Selcuk, Cengiz Akosman, Mehmet Akif Ozturk Ferda Özkan, Özcan Gokce, Basak Oyan. Bilateral synchronous adrenal metastasis of invasive ductal carcinoma treated with multimodality therapy including adrenalectomy and oophorectomy. J Oncol Pharm Pract. 2014 Sep 16. pii: 1078155214551314. [Epub ahead of print].

Presentations at International Scientific Meetings Published in Proceedings

5. Akosman, C., Ç. Ordu, E. Eroğlu, B. Oyan. Development of acute pulmonary hypertension and pulmonary parenchymal infiltrates after bortezomib treatment. 2nd International Leukemia-Lymphoma-Myeloma Congress, İstanbul, 2009; P69.

6. Oyan, B., N. Alan Selçuk, C. Akosman, C. Ordu. The early metabolic effects of zolendronic acid on FDGPET scans in patients with bone metastasis. ASCO annual meeting, Chicago, J. Clin. Oncol., Vol 29 (suppl), Abstract e21168, 2011.

7. Akosman, C., Ç. Ordu, B. Oyan. The acute effects of palonosetron on ECG parameters in patients with cancer. ASCO annual meeting, Chicago, J. Clin. Oncol., Vol 29 (suppl), Abstract e19693, 2011.

8. Ordu Ç., N. Alan Selçuk, C. Akosman, B. Oyan. The prognostic relevance of response evaluation to chemotherapy by FDG-PET/CT in patients with metastatic non-small cell lung cancer. ASCO annual meeting, Chicago, J. Clin. Oncol., Vol 29 (suppl), Abstract e18055, 2011.

Articles Published in National Peer-Reviewed Journals

9. Ordu, Ç., C. Akosman, F.F. Yalnız, M. Kalaycı, I.Doğan Ekici, B. Oyan. Large cell neuroendocrine tumor of gallbladder: A case report and review of the literature. Türkiye Klinikleri J. Case Rep. 21(1); 1-5 (2013).

10. Ö Karadağ Köse, Cengiz Akosman, Murat M Borlu. Evaluation of Videodermoscopic Features of Chemotherapy Induced Alopecias. Turkiye Klinikleri J Dermatol. 2020;30(1):15-21. doi: 10.5336/dermato.2019-73099.

Presentations at National Scientific Meetings Published in Proceedings

11. Ordu Ç., C. Akosman, B. Oyan Uluç. Chemotherapy application in colon cancer cases with liver dysfunction due to metastasis. 18th National Cancer Congress, P104, Antalya, 2009.

12. Ordu Ç., C. Akosman, M Kalaycı, I. Doğan Ekici, B. Oyan. Primary gallbladder large cell neuroendocrine carcinoma: A case report. 18th National Cancer Congress, P105, Antalya, 2009.

13. Akosman C., Ç. Ordu, S. Ercan, N. Alan Selçuk, I. Doğan Ekici, B. Oyan Uluç. Unicentric mixed variant Castleman disease: Use of PET/CT in staging and evaluating treatment response. 18th National Cancer Congress, P357, Antalya, 2009.

14. Ordu Ç., C. Akosman, Ö. Gökçe, B. Oyan. Long-term disease-free survival after metastasectomy in a breast cancer patient presenting with isolated bilateral adrenal metastasis. 18th National Cancer Congress, P028, Antalya, 2009.

15. Akosman, C., Ç. Ordu, F. Özkan, I. Doğan Ekinci, B. Oyan. Recurrence of ovarian serous adenocarcinoma first as carcinosarcoma, then as sarcoma. III. Medical Oncology Congress, Antalya, 2010.

16. Oyan, B, N. Alan Selçuk, C. Akosman, Ç. Ordu. The Early Metabolic Effect of Zolendronic Acid on FDGPET/CT in Patients with Bone Metastasis. 19th National Cancer Congress, S67, Antalya, 2011 (Oral presentation).

17. Akosman, C., Ç. Ordu, B. Oyan. The acute effects of palonosetron on ECG parameters, pulse, and blood pressure in cancer patients. 19th National Cancer Congress, S68, Antalya, 2011 (Oral presentation).

18. Ordu Ç., N. Alan Selçuk, C. Akosman, B. Oyan Uluç. The Effect of Metabolic Response on Prognosis in FDG-PET/CT after Chemotherapy in Advanced Stage Non-Small Cell Lung Cancer. 19th National Cancer Congress, P001, Antalya, 2011.

Other Publications (Theses)

• Internal Medicine Specialization Thesis: The relationship between carotid artery intima media thickness and testosterone levels and comparison with framingham risk scores in diabetic male patients. Year: 2006. Author: CENGİZ AKOSMAN. Supervisor: Uzm Dr Refik Demirtunç / 3rd Internal Medicine Clinic Chief. Location: Haydarpaşa Numune Education and Research Hospital / 4th Internal Medicine Clinic.

• Medical Oncology Minor Branch Specialization Thesis: Acute effects of palonosetron on ECG parameters in cancer patients. Year: 2010. Author: CENGİZ AKOSMAN. Supervisor: DOÇ. DR. BAŞAK OYAN ULUÇ. Location: Yeditepe University / Faculty of Medicine / Department of Internal Medicine / Division of Oncology.

International Citations

• Citing Publication for: Akosman C, N.A. Selcuk, C. Ordu, S. Ercan, I.D. Ekici, B.Oyan. "Unicentric mixed variant Castleman disease associated with Hashimoto disease: the role of PET/CT in staging and evaluating response to the treatment," Cancer Imaging. 2011; 11(1): 52–55.

  • Ghys C. Depierreux M. Ozalp E. Velkeniers B. Cervical Lymph Nodes, Thyroiditis and Ophthalmopathy: The Pleomorphic Face of an Immunoglobulin G4 Related Disease. Eur Thyroid J 2014;3:252-257 (DOI:10.1159/000369204).

  • Mariapaola Cucinotta MD, Angelina Cistaro MD. Castleman's Disease. Atlas of PET/CT in pediatric patients, 2014, pp 241-244.

  • Vance T. Lehman MD, Benjamin J Barrick MD, Mark R. Pittelkow MD, Patrick J. Peller MD, Michael J Camilleri MD, Julia S. Lehman MD. Diagnostic imaging in paraneoplastic autoimmüne multiotgan syndrome: retrospective single site study and literature review of 225 patients. Internationl journal of Dermatology, volume 54, issue 4, pages 424-437, April 2015.

  • Ebru Tatci, Ozlem Ozmen, Yeliz Dadali, İnci Uslu Biner, Atila Gökcek, Funda Demirağ, Funda İncekara and Nuri Aslan. The role of FDG PET/CT in evaluation of mediastinal masses and neurogenic tumors of chest wall. Int J Clin Exp Med. 2015; 8(7): 11146–11152. Published online 2015 Jul 15.

  • Kenneth Miles. Nuclear oncology in Cancer Imaging 2011. Cancer Imaging. 2012; 12(1): 185–186. Published online 2012 May 21. doi:10.1102/1470-7330.2012.0025.

  • Yi Liu, Gang Chen, Xiaoming Qiu, Song Xu, Yi Wu, Renwang Liu, Qinghua Zhou and Jun Chen. Intrapulmonary unicentric Castleman disease mimicking peripheral pulmonary malignancy. Thoracic Cancer, volume 5 issue 6, pages 576-580, November 2014.

• Citing Publications for: Akosman C., C. Ordu, E. Eroglu, B. Oyan. "Development of acute pulmonary hypertension after bortezomib treatment in a patient with multiple myeloma: A case report and the review of the literature", Am J Ther. (2013) Oct 4. [Epub ahead of print].

  • Oliver Drews. The left and right ventricle in the grip of protein degradation: Similarities and unique patterns in regulation. Journel of Molecular and Cellular Cardiology, volume 72, Pages 52-55, July 2014.

  • Reactions weekly, June 2015, Volume 1556, issue 1, p 64. Bortezomib.

  • Samer Alsidawi, Abhimanyu Ghose, Julianne Qualtieri, and Neetu Radhakrishnan. A Case of Multiple Myeloma with Metachronous Chronic Myeloid Leukemia Treated Successfully with Bortezomib, Dexamethasone, and Dasatinib. Case Reports in Oncological Medicine Volume 2014 (2014), Article ID 962526, 4 pages.

• Citing Publication for: Cetin Ordu, Nalan A Selcuk, Cengiz Akosman, Orhan Onder Eren, Elif C Altunok, Turkay Toklu, Basak Oyan. "Comparison of Metabolic and Anatomic Response to Chemotherapy Based on PERCIST and RECIST in Patients with Advanced Stage Non-small Cell Lung Cancer", Asian Pac J Cancer Prev, 16 (1), 321-326.

  • W.-G. Lan, Y.-Z.Hao, D.-H. Xu, P.Wang, Y.-L.Zhou, L.-B.Ma. Serum human epididymis protein 4 is associated with the treatment response of concurrent chemoradiotherapy and prognosis in patients with locally advanced non-small cell lung cancer.